The FDA’s website states, "Currently available data do not show ivermectin is effective against COVID-19."But half of the studies to which the FDA points support using ivermectin against COVID-19, according to the review.
The papers cut against the drug agency’s repeated exhortations for people not to take ivermectin for COVID-19. In Twitter posts, public statements, and emails, FDA officials have repeatedly warned against ivermectin. Some of those statements triggered a lawsuit from doctors who say the agency’s role is to approve drugs, not to issue recommendations. The suit was dismissed this week.
The article includes a list of studies. I noted several that did not support Ivermectin were limited, such as mild cases, or time to resolution. Many did not have combination therapies, further limiting results.
Bangladeshi researchers reported the results from the trial of 363 participants on May 13, 2021, in the Journal of International Medical Research.
"Patients with mild-to-moderate COVID-19 infection treated with ivermectin plus doxycycline recovered earlier, were less likely to progress to more serious disease, and were more likely to be COVID-19 negative by RT-PCR on day 14," they said. PCR has been used to test for COVID-19.
Another paper, published on July 7, 2022, in the International Journal of Infectious Diseases, found that that ivermectin decreased the level of COVID-19 and its viability. Israeli researchers in the randomized, controlled, open label trial compared 47 patients who received ivermectin against 42 who received placebos and said that "ivermectin significantly reduced the time of viral shedding and affected viral viability when initiated in the first week after evidence of infection."
"There were lower viral loads and less viable cultures in the ivermectin group, which shows its anti-SARS-CoV-2 activity," the researchers said.
The FDA does not cite studies on its website to support its statement that data "do not show ivermectin is effective against COVID-19."
"Clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing," the agency adds, providing a link to the U.S. National Library of Medicine’s database.
Of the 88 studies listed there, 56 fall under one of three categories: have not been completed, were completed but results have not been reported, or were completed and have since been retracted or otherwise withdrawn.
So that's 56 more studies 'that do not support the use of Ivermectin! You are NOT a horse!!
Of the remaining 32, 16 found or indicate ivermectin is effective as a COVID-19 treatment or prophylactic, according to the Epoch Times review.
You can review the completed studies (summaries) at the link.Maybe you can understand the FDA's reluctance.